GB0605685D0 - Inhibition of tumour growth - Google Patents

Inhibition of tumour growth

Info

Publication number
GB0605685D0
GB0605685D0 GBGB0605685.7A GB0605685A GB0605685D0 GB 0605685 D0 GB0605685 D0 GB 0605685D0 GB 0605685 A GB0605685 A GB 0605685A GB 0605685 D0 GB0605685 D0 GB 0605685D0
Authority
GB
United Kingdom
Prior art keywords
inhibition
tumour growth
tumour
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0605685.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lytix Biopharma AS
Original Assignee
Lytix Biopharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lytix Biopharma AS filed Critical Lytix Biopharma AS
Priority to GBGB0605685.7A priority Critical patent/GB0605685D0/en
Publication of GB0605685D0 publication Critical patent/GB0605685D0/en
Priority to PCT/GB2007/000993 priority patent/WO2007107748A2/en
Priority to AU2007228574A priority patent/AU2007228574B2/en
Priority to US11/726,172 priority patent/US8283315B2/en
Priority to JP2009500919A priority patent/JP2009530359A/ja
Priority to EP07732085A priority patent/EP2010204A2/en
Priority to CNA2007800154351A priority patent/CN101466391A/zh
Priority to CA2646589A priority patent/CA2646589C/en
Priority to NO20084053A priority patent/NO20084053L/no
Priority to US13/585,232 priority patent/US9109048B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB0605685.7A 1998-08-21 2006-03-21 Inhibition of tumour growth Ceased GB0605685D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB0605685.7A GB0605685D0 (en) 2006-03-21 2006-03-21 Inhibition of tumour growth
CA2646589A CA2646589C (en) 2006-03-21 2007-03-21 Inhibition of tumour growth
JP2009500919A JP2009530359A (ja) 2006-03-21 2007-03-21 腫瘍成長の阻害
AU2007228574A AU2007228574B2 (en) 2006-03-21 2007-03-21 Inhibition of tumour growth
US11/726,172 US8283315B2 (en) 1998-08-28 2007-03-21 Inhibition of tumour growth
PCT/GB2007/000993 WO2007107748A2 (en) 2006-03-21 2007-03-21 Inhibition of tumour growth
EP07732085A EP2010204A2 (en) 2006-03-21 2007-03-21 Inhibition of tumour growth
CNA2007800154351A CN101466391A (zh) 2006-03-21 2007-03-21 对肿瘤生长的抑制
NO20084053A NO20084053L (no) 2006-03-21 2008-09-24 Inhibering av tumorvekst
US13/585,232 US9109048B2 (en) 1998-08-21 2012-08-14 Inhibition of tumor growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0605685.7A GB0605685D0 (en) 2006-03-21 2006-03-21 Inhibition of tumour growth

Publications (1)

Publication Number Publication Date
GB0605685D0 true GB0605685D0 (en) 2006-05-03

Family

ID=36383910

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0605685.7A Ceased GB0605685D0 (en) 1998-08-21 2006-03-21 Inhibition of tumour growth

Country Status (8)

Country Link
EP (1) EP2010204A2 (OSRAM)
JP (1) JP2009530359A (OSRAM)
CN (1) CN101466391A (OSRAM)
AU (1) AU2007228574B2 (OSRAM)
CA (1) CA2646589C (OSRAM)
GB (1) GB0605685D0 (OSRAM)
NO (1) NO20084053L (OSRAM)
WO (1) WO2007107748A2 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0821616D0 (en) * 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
GB201401877D0 (en) * 2014-02-04 2014-03-19 Univ Tromsoe Peptides
JP6813258B2 (ja) * 2014-12-11 2021-01-13 リティックス バイオファーマ エイエス 化学療法の組み合わせ
JP6767096B2 (ja) 2014-12-11 2020-10-14 リティックス バイオファーマ エイエス 免疫チェックポイント阻害剤の組み合わせ
CA2976377A1 (en) * 2015-02-12 2016-08-18 The Johns Hopkins University Inhibition of yap for breaking tumor immune tolerance
GB201601868D0 (en) 2016-02-02 2016-03-16 Lytix Biopharma As Methods
EP4637800A1 (en) 2022-12-20 2025-10-29 Lytix Biopharma AS Compositions comprising an oncolytic peptide and chitosan
WO2024133580A1 (en) 2022-12-20 2024-06-27 Lytix Biopharma As Medical products containing an aqueous formulation of a peptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861478A (en) * 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
DE3854476T2 (de) * 1987-07-06 1996-04-04 Univ Louisiana State Inhibierung von eukaryotischen pathogenen und neoplasmen mit lytischen peptiden.
US5773413A (en) * 1993-06-04 1998-06-30 Demeter Biotechnologies, Ltd. Method of combating mammalian neoplasias, and lytic peptides therefor
IL113244A0 (en) * 1994-04-08 1995-07-31 Demeter Biotech Ltd Method of combating mammalian neoplasia and lytic peptides therefor
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides

Also Published As

Publication number Publication date
WO2007107748A3 (en) 2007-12-06
JP2009530359A (ja) 2009-08-27
AU2007228574A1 (en) 2007-09-27
NO20084053L (no) 2008-11-28
EP2010204A2 (en) 2009-01-07
AU2007228574B2 (en) 2013-06-20
WO2007107748A2 (en) 2007-09-27
CA2646589C (en) 2016-05-03
CA2646589A1 (en) 2007-09-27
CN101466391A (zh) 2009-06-24

Similar Documents

Publication Publication Date Title
IL202154A0 (en) Novel amide derivative for inhibiting the growth of cancer cells
ZA200809203B (en) Rnai-mediated inhibition of tumor necrosis factor alpha-related conditions
IL200596A0 (en) Tetrahydroisoquinolines as tumour growth inhibitors
IL199727A0 (en) Inhibitors of mek
IL197315A0 (en) Treatment of cancer
EP2026843A4 (en) THERAPEUTIC USES OF RTP801L INHIBITORS
ZA201002696B (en) Methods of maintaining or increasing growth or cognitive development
IL227367A (en) Irrigation method
EP2049139A4 (en) TREATMENT OF TUMORS EXPRESSING RAS
SI2029155T1 (sl) Izboljšano zdravljenje multiplega mieloma
IL205324A0 (en) Enhancement of plant growth
IL205831A0 (en) Kinesin inhibitors as cancer therapeutics
ZA200904197B (en) Planting of seedlings
ZA200907337B (en) Methods of increasing plant growth
GB0719997D0 (en) Portease Inhibition
GB0622084D0 (en) Inhibitors of HSP90
EP2160465A4 (en) TUMOR GROWTH-INHIBITING CONNECTIONS AND METHOD FOR THEIR USE
GB0605685D0 (en) Inhibition of tumour growth
GB0701722D0 (en) Inhibition of gene expression
EP2164494A4 (en) Methods of Treatment
GB0723100D0 (en) Treatment of HFnEF
GB201114396D0 (en) Location of basesation
ZA201004090B (en) Methods for the inhibition of scarring
GB0600903D0 (en) Treatment of cancer
AU2007903144A0 (en) Inhibition of Hair Growth

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)